Article info

Incidence and risk factors for herpes zoster in patients with rheumatoid arthritis receiving upadacitinib: a pooled analysis of six phase III clinical trials

Authors

  1. Correspondence to Dr Kevin L Winthrop, School of Public Health, Oregon Health & Science University, Portland, Oregon, USA; winthrop{at}ohsu.edu
View Full Text

Citation

Winthrop KL, Nash P, Yamaoka K, et al
Incidence and risk factors for herpes zoster in patients with rheumatoid arthritis receiving upadacitinib: a pooled analysis of six phase III clinical trials

Publication history

  • Received May 20, 2021
  • Accepted September 22, 2021
  • First published October 6, 2021.
Online issue publication 
January 12, 2022

Article Versions

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.